You have 9 free searches left this month | for more free features.

Condition

Advanced Solid Tumors (1)

Locally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Sign in for free

Phase

phase 1 (2)

Sponsor

Astellas Pharma Global Development, Inc. (1)

Astellas Pharma Inc (1)

Collaborator

Merck Sharp & Dohme LLC (1)

Intervention

asp1948 (2)

nivolumab (1)

pembrolizumab (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

asp1948

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Locally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies Trial in Chuo-ku (ASP1948)

Completed

Locally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies

ASP1948

Chuo-ku, Tokyo, Japan

Site JP810001

Jan 17, 2023

Advanced Solid Tumors Trial in Worldwide (ASP1948, nivolumab, pembrolizumab)

Active, not recruiting

Advanced Solid Tumors

ASP1948
+2 more

New Haven, Connecticut
+41 more

Jan 10, 2023